Cargando…
Efficacy of Ciprofloxacin/Celecoxib combination in zebrafish models of amyotrophic lateral sclerosis
OBJECTIVE: To evaluate the efficacy of a fixed‐dose combination of two approved drugs, Ciprofloxacin and Celecoxib, as a potential therapeutic treatment for amyotrophic lateral sclerosis (ALS). METHODS: Toxicity and efficacy of Ciprofloxacin and Celecoxib were tested, each alone and in distinct rati...
Autores principales: | Goldshtein, Hagit, Muhire, Alexandre, Petel Légaré, Virginie, Pushett, Avital, Rotkopf, Ron, Shefner, Jeremy M., Peterson, Randall T, Armstrong, Gary A. B., Russek‐ Blum, Niva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545590/ https://www.ncbi.nlm.nih.gov/pubmed/32915525 http://dx.doi.org/10.1002/acn3.51174 |
Ejemplares similares
-
A Synthetic SOD/Catalase Mimic Compound for the Treatment of ALS
por: Soll, Matan, et al.
Publicado: (2021) -
Augmentation of spinal cord glutamatergic synaptic currents in zebrafish primary motoneurons expressing mutant human TARDBP (TDP-43)
por: Petel Légaré, Virginie, et al.
Publicado: (2019) -
Cytokinesis-block micronucleus assay of celecoxib and celecoxib derivatives
por: Reimann, Hauke, et al.
Publicado: (2020) -
Quantifying Disease Progression in Amyotrophic Lateral Sclerosis
por: Simon, Neil G, et al.
Publicado: (2014) -
Skeletal muscle in amyotrophic lateral sclerosis
por: Shefner, Jeremy M, et al.
Publicado: (2023)